drugset / Trial / NCT03219203
Immunologic Response of Hepatitis B Vaccine
RandomizedParallel-groupOpen-labelPrevention
Summary
This study aims to evaluate the immunologic response to the two hepatitis B virus (HBV) vaccination booster strategies in previously vaccinated HIV-infected adults at Maharaj Nakorn Chiang Mai Hospital.
Timeline
- Start
- 2017-07-01
- Primary completion
- 2018-07-01
- Completion
- 2018-10-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hepatitis B vaccine | Vaccine | 20 ug | Intramuscular |